Thus, a 68Ga‐PSMA PET performed at very early PSA values may have higher chances of false negative findings, and thus, it may miss additional nodal metastases, and/or it may diagnose oligometastatic prostate cancer although the disease is already systemic. The gene discussed is FOLH1; the disease is prostate carcinoma.